Seeking Alpha

Aria secures Iclusig commercial deal for Israel

  • Ariad Pharmaceuticals (ARIA +1.2%) grants Medison Pharma Ltd exclusive rights to commercialize Iclusig (ponatinib) in Israel. Under the terms of the agreement, Medison will be responsible for sales and marketing, medical affairs, regulatory support and pricing/reimbursement approval while Ariad remains the Marketing Authorization Holder.
  • Iclusig is currently under regulatory review in Israel. Ariad expects clearance in 2H 2015.
From other sites
Comments (5)
  • dpa1224
    , contributor
    Comments (5) | Send Message
     
    Have to wonder about timing of this announcement, two days before disclosure of earnings. Expect earnings report to be shoddy.
    5 Aug 2014, 01:24 PM Reply Like
  • stk28097
    , contributor
    Comments (224) | Send Message
     
    You buy this stock because Icahns former man Denner is running the show and is gonna sell it for $20 a share. Not because of the earnings.
    5 Aug 2014, 02:43 PM Reply Like
  • dpa1224
    , contributor
    Comments (5) | Send Message
     
    How can this stock be worth $20? They continue to lose money. The money they recently borrowed was needed for one reason, they need it to stay afloat, because of the lack of income. Denner is human. He also can make mistakes
    5 Aug 2014, 03:50 PM Reply Like
  • GameKing13
    , contributor
    Comments (509) | Send Message
     
    DPA1224:
    So you're recommending a "sell"?
    5 Aug 2014, 04:34 PM Reply Like
  • stk28097
    , contributor
    Comments (224) | Send Message
     
    All new pharma/biotech companies loose money. You guys shouldn't be in this type of stock due to your lack of understanding on a company like this. It was trading at $20 last year before they halted the sales of larger doses. In the interim the lower doses were priced cheaper resulting in smaller sales. However ARIA has said they will raise the lower dose price. And Denner isn't going to make "a mistake" he's not some Joe Shmoe. Do some home work on stocks you buy.
    5 Aug 2014, 05:57 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs